Evidence map›Paper›PMID 39132243›Full record

ArticleBioinformation2024

Synthesis and molecular docking analysis of MBH adducts' derived amides as potential

Hamid Ullah, Sadia Majid, Asma Abro, Taj Ur Rahman, Abdul Majeed Khan, Mehboob Ahmed, Muhammad Asif, Asma Yousafzai, Riffat Ullh, Peter Natesan Pushparaj and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hamid UllahDepartment of Chemistry, Balochistan University of Information Technology, Engineering and Management Sciences, Takatu Campus, Quetta 87300, Pakistan.
Sadia MajidDepartment of Chemistry, Mohi-Ud-Din Islamic University Nerian Sharif, AJ & K, Pakistan.
Asma AbroDepartment of Biotechnology, BUITEMS, Takatu Campus, Quetta, Pakistan.
Taj Ur RahmanDepartment of Chemistry, Mohi-Ud-Din Islamic University Nerian Sharif, AJ & K, Pakistan.
Abdul Majeed KhanGeneral Studies Department, Jubail Industrial College, Jubail Industrial City 31961, Saudi Arabia.
Mehboob AhmedDepartment of Biotechnology, BUITEMS, Takatu Campus, Quetta, Pakistan.
Muhammad AsifDepartment of Biotechnology & ORIC, BUITEMS, Takatu Campus, Quetta, Pakistan.
Asma YousafzaiDepartment of Biotechnology, BUITEMS, Takatu Campus, Quetta, Pakistan.
Riffat UllhH. E. J. Research institute of chemistry, ICCBS, University of Karachi, Pakistan.
Peter Natesan PushparajCenter of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Mahmood RasoolCenter of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Humans suffer from various diseases that require more specific drugs to target them. Among the different potent agents,

Indexed as

ADME propertiesantibacterial amidesin silico studiesMBH adductsSynthesisβ-lactamase inhibitors

Identifiers

PMID39132243
PMCPMC11309101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.